{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Lipocine Inc."},"Symbol":{"label":"Symbol","value":"LPCN"},"Address":{"label":"Address","value":"675 ARAPEEN DRIVE,SUITE 202, SALT LAKE CITY, Utah, 84108, United States"},"Phone":{"label":"Phone","value":"+1 801 994-7383"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other products in the pipeline such as LPCN 1144 LPCN 1148 and LPCN 1107."},"CompanyUrl":{"label":"Company Url","value":"https://www.lipocine.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anthony DelConte","title":"Chief Medical Director"},{"name":"Mahesh V. Patel","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}